Herbschleb-Voogt E, Ten Kate J, Meera Khan P
Anticancer Res. 1983 Mar-Apr;3(2):95-100.
Several observations by independent investigators in the past have indicated that adenosine deaminase complexing protein (ADCP), present in considerable quantities in certain human tissues, was absent or decreased in the cancers originated from them. During the present study, electrophoretic analysis of adenosine deaminase (ADA) isozymes and radioimmunoassay for ADCP in the primary fibroblasts and the transformed as well as certain tumor derived cell lines have demonstrated that ADCP present in large quantities in the primary cells was absent or nearly absent in the transformed or tumor-derived cell lines. Though the mechanisms involved are not yet clear, the above observations indicate that ADCP has the potentials of a useful marker in the studies on transformed cells and cancer tissues.
过去,一些独立研究人员的观察表明,腺苷脱氨酶复合蛋白(ADCP)在某些人体组织中大量存在,但源自这些组织的癌症中却不存在或减少。在本研究中,对原代成纤维细胞、转化细胞以及某些肿瘤衍生细胞系中的腺苷脱氨酶(ADA)同工酶进行电泳分析,并对ADCP进行放射免疫测定,结果表明,原代细胞中大量存在的ADCP在转化细胞或肿瘤衍生细胞系中不存在或几乎不存在。尽管其中涉及的机制尚不清楚,但上述观察结果表明,ADCP在转化细胞和癌组织的研究中具有作为有用标志物的潜力。